首页 > 最新文献

JAMA Oncology最新文献

英文 中文
Is Regional Nodal Radiotherapy Necessary for Patients With cN1 and ypN0 Breast Cancer After Neoadjuvant Chemotherapy?-Reply. cN1和ypN0乳腺癌患者在新辅助化疗后是否需要局部淋巴结放疗?
IF 28.4 1区 医学 Q1 ONCOLOGY Pub Date : 2022-05-12 DOI: 10.1001/jamaoncol.2022.0316
A. Barrio, G. Montagna, M. Morrow
{"title":"Is Regional Nodal Radiotherapy Necessary for Patients With cN1 and ypN0 Breast Cancer After Neoadjuvant Chemotherapy?-Reply.","authors":"A. Barrio, G. Montagna, M. Morrow","doi":"10.1001/jamaoncol.2022.0316","DOIUrl":"https://doi.org/10.1001/jamaoncol.2022.0316","url":null,"abstract":"","PeriodicalId":14850,"journal":{"name":"JAMA Oncology","volume":" ","pages":""},"PeriodicalIF":28.4,"publicationDate":"2022-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41638844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Analysis of Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy Using Pooled Trial Data Matched by Propensity Score-Reply. 使用倾向评分-应答匹配的合并试验数据分析接受免疫治疗的患者放射治疗与不良事件风险的关联。
IF 28.4 1区 医学 Q1 ONCOLOGY Pub Date : 2022-05-05 DOI: 10.1001/jamaoncol.2022.0880
C. Weinstock, Anup K Amatya, J. Beaver
{"title":"Analysis of Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy Using Pooled Trial Data Matched by Propensity Score-Reply.","authors":"C. Weinstock, Anup K Amatya, J. Beaver","doi":"10.1001/jamaoncol.2022.0880","DOIUrl":"https://doi.org/10.1001/jamaoncol.2022.0880","url":null,"abstract":"","PeriodicalId":14850,"journal":{"name":"JAMA Oncology","volume":" ","pages":""},"PeriodicalIF":28.4,"publicationDate":"2022-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47028866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy Using Pooled Trial Data Matched by Propensity Score. 使用倾向评分匹配的汇总试验数据分析接受免疫治疗患者的放射治疗与不良事件风险的相关性。
IF 28.4 1区 医学 Q1 ONCOLOGY Pub Date : 2022-05-05 DOI: 10.1001/jamaoncol.2022.0877
T. Nopsopon, M. Y. Wu, D. Sardana
{"title":"Analysis of Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy Using Pooled Trial Data Matched by Propensity Score.","authors":"T. Nopsopon, M. Y. Wu, D. Sardana","doi":"10.1001/jamaoncol.2022.0877","DOIUrl":"https://doi.org/10.1001/jamaoncol.2022.0877","url":null,"abstract":"","PeriodicalId":14850,"journal":{"name":"JAMA Oncology","volume":" ","pages":""},"PeriodicalIF":28.4,"publicationDate":"2022-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45716059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Colorectal Cancer Incidence Among Adults Younger Than 50 Years-Understanding Findings From Observational Studies of Lower Gastrointestinal Endoscopy. 50岁以下成人的结直肠癌发病率——了解下消化道内镜观察性研究的发现。
IF 28.4 1区 医学 Q1 ONCOLOGY Pub Date : 2022-05-05 DOI: 10.1001/jamaoncol.2022.0863
G. Calip, N. Meropol, D. Weinberg
{"title":"Colorectal Cancer Incidence Among Adults Younger Than 50 Years-Understanding Findings From Observational Studies of Lower Gastrointestinal Endoscopy.","authors":"G. Calip, N. Meropol, D. Weinberg","doi":"10.1001/jamaoncol.2022.0863","DOIUrl":"https://doi.org/10.1001/jamaoncol.2022.0863","url":null,"abstract":"","PeriodicalId":14850,"journal":{"name":"JAMA Oncology","volume":" ","pages":""},"PeriodicalIF":28.4,"publicationDate":"2022-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46838039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Evaluation of Safety of Treatment With Anti–Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors 抗表皮生长因子受体抗体-药物偶联物MRG003治疗晚期实体瘤的安全性评价
IF 28.4 1区 医学 Q1 ONCOLOGY Pub Date : 2022-05-05 DOI: 10.1001/jamaoncol.2022.0503
M. Qiu, Yang Zhang, Ye Guo, W. Guo, Weiqi Nian, W. Liao, Zhongyuan Xu, Wenxue Zhang, Hongzhe Zhao, Xiaoli Wei, L. Xue, W. Tang, Yunteng Wu, G. Ren, Ling Wang, Jingle Xi, Yongshuai Jin, Hu Li, Chaohong Hu, R. Xu
Key Points Question What is the safety and antitumor activity of MRG003 in patients with advanced solid tumors? Findings In this phase 1 clinical trial of 61 patients with advanced or metastatic solid tumors, treatment with MRG003 exhibited manageable safety and showed encouraging antitumor activity in squamous cell carcinomas of the head and neck and nasopharyngeal carcinoma, with a confirmed objective response rates of 40% and 44%, respectively. Meaning The study findings suggest the safety of treatment with MRG003 and an acceptable tolerance in most patients with epidermal growth factor receptor–expressing solid tumors, as well as encouraging antitumor activity in patients with squamous cell carcinomas of the head and neck and nasopharyngeal carcinoma.
要点问题MRG003在晚期实体瘤患者中的安全性和抗肿瘤活性是什么?研究结果在这项针对61名晚期或转移性实体瘤患者的1期临床试验中,MRG003治疗显示出可控的安全性,并在头颈部鳞状细胞癌和鼻咽癌中显示出令人鼓舞的抗肿瘤活性,经证实的客观有效率分别为40%和44%。研究结果表明,MRG003治疗的安全性和对大多数表皮生长因子受体表达实体瘤患者的可接受耐受性,以及对头颈部鳞状细胞癌和鼻咽癌患者的抗肿瘤活性。
{"title":"Evaluation of Safety of Treatment With Anti–Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors","authors":"M. Qiu, Yang Zhang, Ye Guo, W. Guo, Weiqi Nian, W. Liao, Zhongyuan Xu, Wenxue Zhang, Hongzhe Zhao, Xiaoli Wei, L. Xue, W. Tang, Yunteng Wu, G. Ren, Ling Wang, Jingle Xi, Yongshuai Jin, Hu Li, Chaohong Hu, R. Xu","doi":"10.1001/jamaoncol.2022.0503","DOIUrl":"https://doi.org/10.1001/jamaoncol.2022.0503","url":null,"abstract":"Key Points Question What is the safety and antitumor activity of MRG003 in patients with advanced solid tumors? Findings In this phase 1 clinical trial of 61 patients with advanced or metastatic solid tumors, treatment with MRG003 exhibited manageable safety and showed encouraging antitumor activity in squamous cell carcinomas of the head and neck and nasopharyngeal carcinoma, with a confirmed objective response rates of 40% and 44%, respectively. Meaning The study findings suggest the safety of treatment with MRG003 and an acceptable tolerance in most patients with epidermal growth factor receptor–expressing solid tumors, as well as encouraging antitumor activity in patients with squamous cell carcinomas of the head and neck and nasopharyngeal carcinoma.","PeriodicalId":14850,"journal":{"name":"JAMA Oncology","volume":"8 1","pages":"1042 - 1046"},"PeriodicalIF":28.4,"publicationDate":"2022-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47275871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Colorectal Cancer Screening in the US-Still Putting the Cart Before the Horse? 美国的结直肠癌筛查:还是本末倒置?
IF 28.4 1区 医学 Q1 ONCOLOGY Pub Date : 2022-05-05 DOI: 10.1001/jamaoncol.2022.0500
Ricardo J. Bello, G. Chang, N. Massarweh
{"title":"Colorectal Cancer Screening in the US-Still Putting the Cart Before the Horse?","authors":"Ricardo J. Bello, G. Chang, N. Massarweh","doi":"10.1001/jamaoncol.2022.0500","DOIUrl":"https://doi.org/10.1001/jamaoncol.2022.0500","url":null,"abstract":"","PeriodicalId":14850,"journal":{"name":"JAMA Oncology","volume":" ","pages":""},"PeriodicalIF":28.4,"publicationDate":"2022-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43048173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
JAMA Oncology. 《美国医学会杂志肿瘤学》。
IF 28.4 1区 医学 Q1 ONCOLOGY Pub Date : 2022-05-01 DOI: 10.1001/jamaoncol.2021.5496
{"title":"JAMA Oncology.","authors":"","doi":"10.1001/jamaoncol.2021.5496","DOIUrl":"https://doi.org/10.1001/jamaoncol.2021.5496","url":null,"abstract":"","PeriodicalId":14850,"journal":{"name":"JAMA Oncology","volume":"8 5 1","pages":"669"},"PeriodicalIF":28.4,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42031472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concerns Remain Regarding the Association of Sitting Time and Physical Activity With Cancer Survivorship-Reply. 坐着时间和体育活动与癌症幸存者的关系仍然令人担忧。
IF 28.4 1区 医学 Q1 ONCOLOGY Pub Date : 2022-04-28 DOI: 10.1001/jamaoncol.2022.0874
C. Cao, C. Friedenreich, L. Yang
{"title":"Concerns Remain Regarding the Association of Sitting Time and Physical Activity With Cancer Survivorship-Reply.","authors":"C. Cao, C. Friedenreich, L. Yang","doi":"10.1001/jamaoncol.2022.0874","DOIUrl":"https://doi.org/10.1001/jamaoncol.2022.0874","url":null,"abstract":"","PeriodicalId":14850,"journal":{"name":"JAMA Oncology","volume":" ","pages":""},"PeriodicalIF":28.4,"publicationDate":"2022-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41938829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Concerns Remain Regarding the Association of Sitting Time and Physical Activity With Cancer Survivorship. 人们仍然关注久坐时间和身体活动与癌症存活之间的关系。
IF 28.4 1区 医学 Q1 ONCOLOGY Pub Date : 2022-04-28 DOI: 10.1001/jamaoncol.2022.0871
T. Goto
{"title":"Concerns Remain Regarding the Association of Sitting Time and Physical Activity With Cancer Survivorship.","authors":"T. Goto","doi":"10.1001/jamaoncol.2022.0871","DOIUrl":"https://doi.org/10.1001/jamaoncol.2022.0871","url":null,"abstract":"","PeriodicalId":14850,"journal":{"name":"JAMA Oncology","volume":" ","pages":""},"PeriodicalIF":28.4,"publicationDate":"2022-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44292750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differently. 不同。
IF 28.4 1区 医学 Q1 ONCOLOGY Pub Date : 2022-04-28 DOI: 10.1001/jamaoncol.2022.0156
Wendy Tong
{"title":"Differently.","authors":"Wendy Tong","doi":"10.1001/jamaoncol.2022.0156","DOIUrl":"https://doi.org/10.1001/jamaoncol.2022.0156","url":null,"abstract":"","PeriodicalId":14850,"journal":{"name":"JAMA Oncology","volume":" ","pages":""},"PeriodicalIF":28.4,"publicationDate":"2022-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44994858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
JAMA Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1